Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer
Background. The purpose of this study was to analyze SUMO activating enzyme subunit 1 (SAE1) expression in breast cancer (BC). Through bioinformatics analysis and in vitro experiments, the biological function and possibly associated signal pathways of SAE1 in BC were further analyzed. Methods. Bioin...
Saved in:
Main Authors: | Hong Liu, Jing Wang, Yunhai Li, Feng Luo, Lei Xing |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | The Breast Journal |
Online Access: | http://dx.doi.org/10.1155/2024/2981722 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Case of Anti-SAE1 Dermatomyositis
by: Max de Vries, et al.
Published: (2022-01-01) -
The role of HSPA14 in breast cancer: implications for tumorigenesis, immune response modulation, and personalized therapies
by: Ruipeng Zhao, et al.
Published: (2025-12-01) -
Risk management application in a Baja SAE team
by: Breno Ferreira Barrados Chorro, et al.
Published: (2023-08-01) -
Human Mesenchymal Stem Cells as Mediators of Breast Carcinoma Tumorigenesis and Progression
by: Lyndsay V. Rhodes, et al.
Published: (2010-01-01) -
Design of double stage springs for Baja SAE type vehicles
by: Pedro Márcio do Carmo Silva, et al.
Published: (2023-09-01)